Clinical Trial Update: Pharmacokinetics - Pharmacodynamic Study of HT-2157 in Healthy Subjects and in Patients With Major Depressive Disorder [Phase 1, Phase 2]

View source ↗

Summary

The study assessed the pharmacokinetics and pharmacodynamics of HT-2157 in healthy volunteers (Phase 1) and in patients with major depressive disorder (Phase 2)…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Major Depressive Disorder

Drugs mentioned

• HT-2157

Snippet

Sponsor: Dart NeuroScience, LLC | Conditions: Healthy Volunteers (Part 1), Major Depressive Disorder (Part 2) | Phase 1, Phase 2 | Status: COMPLETED